Nuzenio

Matt Phipps Reiterates

Matt Phipps Reiterates entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 5 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Genmab: Buy Rating Backed by Epkinly Outperformance and $8 Billion Peak-Sales Pipeline Potential - TipRanksTipRanks · Fri, 07 Aug 2026 02:35:43 GMTAnalyst Matt Phipps Maintains Buy on NewAmsterdam as PREVAIL Interim Design Bolsters Cardiovascular Efficacy Odds and Risk-Reward Profile - TipRanksTipRanks · Thu, 06 Aug 2026 23:36:05 GMTMatt Phipps Reiterates Buy on Insmed as Brinsupri Outperformance, Raised Guidance and Higher Peak Sales Outlook Strengthen Long-Term Growth Story - TipRanksTipRanks · Thu, 06 Aug 2026 18:36:05 GMTAnalyst Reaffirms Buy on Context Therapeutics, Citing Undervalued Pipeline and CTIM-76 as Key Long-Term Driver - TipRanksTipRanks · Thu, 06 Aug 2026 17:52:17 GMTTenax Therapeutics: Buy Rating Ahead of August LEVEL Phase III Catalyst, Attractive Risk/Reward in Underserved PH-HFpEF Market - TipRanksTipRanks · Fri, 31 Jul 2026 18:41:09 GMT

Timeline

Fri, 07 Aug 2026 02:35:43 GMTGenmab: Buy Rating Backed by Epkinly Outperformance and $8 Billion Peak-Sales Pipeline Potential - TipRanks
Thu, 06 Aug 2026 23:36:05 GMTAnalyst Matt Phipps Maintains Buy on NewAmsterdam as PREVAIL Interim Design Bolsters Cardiovascular Efficacy Odds and Risk-Reward Profile - TipRanks
Thu, 06 Aug 2026 18:36:05 GMTMatt Phipps Reiterates Buy on Insmed as Brinsupri Outperformance, Raised Guidance and Higher Peak Sales Outlook Strengthen Long-Term Growth Story - TipRanks
Thu, 06 Aug 2026 17:52:17 GMTAnalyst Reaffirms Buy on Context Therapeutics, Citing Undervalued Pipeline and CTIM-76 as Key Long-Term Driver - TipRanks
Fri, 31 Jul 2026 18:41:09 GMTTenax Therapeutics: Buy Rating Ahead of August LEVEL Phase III Catalyst, Attractive Risk/Reward in Underserved PH-HFpEF Market - TipRanks

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Matt Phipps Reiterates.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.